投稿咨詢
Thoracic Cancer aims to facilitate international collaboration and exchange of comprehensive and cutting-edge information on basic, translational, and applied clinical research in lung cancer, esophageal cancer, mediastinal cancer, breast cancer and other thoracic malignancies. Prevention, treatment and research relevant to Asia-Pacific is a focus area, but submissions from all regions are welcomed. The editors encourage contributions relevant to prevention, general thoracic surgery, medical oncology, radiology, radiation medicine, pathology, basic cancer research, as well as epidemiological and translational studies in thoracic cancer. Thoracic Cancer is the official publication of the Chinese Society of Lung Cancer, International Chinese Society of Thoracic Surgery and is endorsed by the Korean Association for the Study of Lung Cancer and the Hong Kong Cancer Therapy Society.
The Journal publishes a range of article types including: Editorials, Invited Reviews, Mini Reviews, Original Articles, Clinical Guidelines, Technological Notes, Imaging in thoracic cancer, Meeting Reports, Case Reports, Letters to the Editor, Commentaries, and Brief Reports.
《Thoracic Cancer》是一本由WILEY出版商出版的專業醫學期刊，該刊創刊于2010年，刊期12 issues/year，該刊已被國際權威數據庫SCIE收錄。在中科院最新升級版分區表中，該刊分區信息為大類學科：醫學 3區，小類學科：腫瘤學 3區；呼吸系統 3區；在JCR（Journal Citation Reports）分區等級為Q3。該刊發文范圍涵蓋腫瘤學等領域，旨在及時、準確、全面地報道國內外腫瘤學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等，促進學術交流，鼓勵學術創新。2021年影響因子為3.223，平均審稿速度平均2月。
| 大類學科 | 分區 | 小類學科 | 分區 | Top期刊 | 綜述期刊 |
| 醫學 | 3區 | ONCOLOGY 腫瘤學 RESPIRATORY SYSTEM 呼吸系統 | 3區 3區 | 否 | 否 |
| JCR分區等級 | JCR所屬學科 | 分區 | 影響因子 |
| Q3 | RESPIRATORY SYSTEM | Q3 | 3.223 |
| ONCOLOGY | Q3 |
| 影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
| 3.223 | 20 | 96.17% | 94.16% | 開放 | 平均2月 |
課題、SCI/EI/SSCI怎么寫？